Physiological Responses to Basketball-Specific Interval Exercise in Female Basketball Players

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age16-22
SponsorPoznan University of Physical Education

About this trial

This study aims to evaluate the effects of interval exercise on metabolic and inflammatory responses, energy substrate utilization, and fatigue in trained female basketball players. High-intensity intermittent exercise is a key component of basketball performance and induces substantial metabolic and physiological stress. However, the acute relationships between exercise-induced metabolic changes, inflammatory responses, substrate utilization, and fatigue in female basketball players remain insufficiently understood.

In this prospective interventional study, eligible female basketball players will complete a standardized interval exercise protocol designed to replicate the physiological demands of competitive basketball. Physiological, biochemical, and perceptual measurements will be collected before exercise, immediately after exercise, and during recovery. Primary outcomes include changes in metabolic and inflammatory biomarkers, energy substrate utilization, and fatigue-related responses. Secondary outcomes include selected physiological and performance-related variables associated with recovery from high-intensity interval exercise.

The findings of this study will improve the understanding of the physiological responses to interval exercise in female basketball players and may contribute to the development of evidence-based training and recovery strategies aimed at optimizing performance and athlete health.

Eligibility criteria

Qualifiers

Female, aged 16-22 years.

Regular participation in organized basketball training.

Current medical clearance for sports participation.

No contraindications to high-intensity physical exercise.

Disqualifiers

Current musculoskeletal injury or any condition preventing maximal exercise.

Metabolic, cardiovascular, inflammatory, or other chronic diseases affecting exercise capacity or study outcomes.

Current use of anti-inflammatory medications.

Use of supplements or substances that may influence the measured metabolic or inflammatory parameters.

Trial design

Treatments tested in this trial

  • Yo-Yo Intermittent Recovery Test Level 1 (Yo-Yo IR1)

Treatment groups

25 Participants
are divided into 1 treatment group